David Krempa - Chief Business Officer at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
ETON on Nasdaq
All Insider Reports
All Insider Reports

David Krempa - trading volume in the past year for Eton Pharmaceuticals, Inc.

Holdings reported by David Krempa for Eton Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 613K $9.02M $14.73 Jun 16, 2025 Direct
Restricted Stock Units 25.9K $207K $7.98 Jan 3, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 38.6K Jan 3, 2025 Direct Common Stock

Transactions reported by David Krempa for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.